Ardelyx (ARDX) Current Leases (2019 - 2026)
Ardelyx (ARDX) reported Current Leases of $1.5 million for Q1 2026, up 15.98% on a YoY basis from $1.3 million in Q1 2025, and up 2.1% quarter-over-quarter from $1.5 million in Q4 2025.
Ardelyx (ARDX) Current Leases (2019 - 2026) Analysis & Trends
Ardelyx has reported Current Leases for 8 years, with the latest figure at $1.5 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 15.98% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (up 15.98% YoY), and the FY2025 full-year result was $1.5 million, down 5.31% from the prior year.
- Current Leases for Q1 2026 stood at $1.5 million, up from $1.5 million in the prior quarter.
- The five-year high for Current Leases was $4.4 million in Q4 2023, with the low at $1.2 million in Q2 2025.
- Historically, Current Leases has averaged $3.0 million across 5 years, with a median of $3.6 million in 2022.
- Annual changes were most pronounced in 2022 — Current Leases surged 154.39% — and 2025, when it sank 69.82%.
- Ardelyx's Current Leases stood at $3.9 million in 2022, then grew by 13.89% to $4.4 million in 2023, then slumped by 64.78% to $1.6 million in 2024, then slipped by 5.31% to $1.5 million in 2025, then increased by 2.1% to $1.5 million in 2026.
- The last three Current Leases figures came in at $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 1.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.51 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 2.57 Mn |
| Jun 30, 2024 | 3.55 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | 4.44 Mn |
| Sep 30, 2023 | 4.32 Mn |
| Jun 30, 2023 | 4.11 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 3.89 Mn |
| Sep 30, 2022 | 3.79 Mn |
| Jun 30, 2022 | 3.69 Mn |
| Mar 31, 2022 | 3.59 Mn |
| Dec 31, 2021 | 3.49 Mn |
| Sep 30, 2021 | 3.39 Mn |
| Jun 30, 2021 | 3.18 Mn |